NCT07286266 2026-03-19
A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)
GlaxoSmithKline
Phase 3 Not yet recruiting
GlaxoSmithKline
National Cancer Institute (NCI)
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
AbbVie
Milton S. Hershey Medical Center
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
SUNHO(China)BioPharmaceutical CO., Ltd.